comparemela.com

Latest Breaking News On - Mindleap health - Page 2 : comparemela.com

Mydecine Innovations Group Inc to launch Special Access Support and Supply Program broadening access to psychedelic-assisted psychotherapy for patients

Through the program, healthcare practitioners can purchase a package including cGMP psilocybin and MDMA, investigative brochures, therapy.

Josh bartchRakesh jetlyJohns hopkins universityMydecine innovations group incHealth canada special access programMindleap healthHealth canadaHealth canada schedulei drugsSpecial access supportSupply programSpecial access programSubstances dealer

NA Proactive news snapshot: Gratomic Inc, Empress Royalty Corp, Vuzix Corporation, Kontrol Technologies Corp, Boosh Plant-Based Brands Inc, Todos Medical Ltd, BetterLife Pharma Inc, Milestone Scientific Inc UPDATE

A glance at some of the day s highlights from the Proactive Investors US and Canada newswires

United statesUnited kingdomClayton valleyNorth lincolnshireBritish columbiaCapim grossoBirch bayCascade rangeEvan sohnMark iretonPaul traversDaniel luKarim nanjiNader pourhassanStaci bogue buchholzLarry reaugh

Mydecine Agrees To LOI With Maya For Development Of Novel Prescription Platform

Mydecine has signed an agreement with Maya that sets the stage for the parties to collaborate on a novel prescription digital therapeutic platform

Damon michaelsJohns hopkins universityMindleap health

Mydecine Signs LOI with Maya to Co-Develop a Novel

DENVER, Dec. 22, 2021 (GLOBE NEWSWIRE) Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NF.F) (“Mydecine” or the “Company”), a biotechnology.

United statesMorgan kervitskyDamon michaelsJoshua bartchMindleap healthJohns hopkins universityMydecine innovations group incMindleap health incMydecine innovations groupMydecine coColorado public benefit corporationInnovations groupDigital therapeuticsMydecine co founderChief executiveAequitas neo exchange myco ne

Mydecine Innovations Group Inc to work with Maya to develop a novel digital therapeutics platform for more personalized patient care

The agreement will allow Mydecine to enhance its existing Mindleap Health digital product to create more personalized treatments for patients

Damon michaelsJohns hopkins universityMydecine innovations group incMindleap healthDrug administrationColorado based mayaDigital therapeutics

vimarsana © 2020. All Rights Reserved.